A round of Series B financing brought in $9 million for Rapid Medical, an Israeli developer of neurovascular interventional devices. The money will be used for securing FDA approvals for the company's TIGERTRIEVER stentriever and its COMANECI aneurysm collar bridging device, as well as to market the devices in Europe.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.